[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Oral Antidiabetic Drugs Market Data Survey Report 2025

April 2018 | 82 pages | ID: G2ADE421037EN
HeyReport

US$ 1,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

The global Oral Antidiabetic Drugs market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:
  • Global market size and forecast
  • Regional market size, production data and export & import
  • Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
  • Major Application
  • Major Type
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
  • Eli Lilly
  • Merck
  • Pfizer
  • Abbott
  • Biocon
  • Sanofi
  • Sanofi
  • Novartis
  • Novo Nordisk
  • Boehringer Ingelheim
  • Takeda Pharmaceuticals
  • Oramed Pharmaceuticals
  • Jiangsu Wanbang
  • Nanjing Xinbai
Major applications as follows:
  • Hospitals
  • Clinics
  • Others
Major Type as follows:
  • Sulfonylureas
  • Biguanides
  • Meglitinides
  • Alpha-glucosidase Inhibitors
  • Others
Regional market size, production data and export & import:
  • Asia-Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa
1 GLOBAL MARKET OVERVIEW

1.1 Scope of Statistics
  1.1.1 Scope of Products
  1.1.2 Scope of Manufacturers
  1.1.3 Scope of Application
  1.1.5 Scope of Regions/Countries
1.2 Global Market Size

2 REGIONAL MARKET

2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade

3 KEY MANUFACTURERS

3.1 Eli Lilly
  3.1.2 Company Information
  3.1.2 Product Specifications
  3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Merck
  3.2.1 Company Information
  3.2.2 Product Specifications
  3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Pfizer
  3.3.1 Company Information
  3.3.2 Product Specifications
  3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Abbott
  3.4.1 Company Information
  3.4.2 Product Specifications
  3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Biocon
  3.5.1 Company Information
  3.5.2 Product Specifications
  3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Sanofi
  3.6.1 Company Information
  3.6.2 Product Specifications
  3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Sanofi
  3.7.1 Company Information
  3.7.2 Product Specifications
  3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Novartis
  3.8.1 Company Information
  3.8.2 Product Specifications
  3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Novo Nordisk
  3.9.1 Company Information
  3.9.2 Product Specifications
  3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 Boehringer Ingelheim
  3.10.1 Company Information
  3.10.2 Product Specifications
  3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Takeda Pharmaceuticals
3.12 Oramed Pharmaceuticals
3.13 Jiangsu Wanbang
3.14 Nanjing Xinbai

4 MAJOR APPLICATION

4.1 Hospitals
  4.1.1 Overview
  4.1.2 Hospitals Market Size and Forecast
4.2 Clinics
  4.2.1 Overview
  4.2.2 Clinics Market Size and Forecast
4.3 Others
  4.3.1 Overview
  4.3.2 Others Market Size and Forecast

5 MARKET BY TYPE

5.1 Sulfonylureas
  5.1.1 Overview
  5.1.2 Sulfonylureas Market Size and Forecast
5.2 Biguanides
  5.2.1 Overview
  5.2.2 Biguanides Market Size and Forecast
5.3 Meglitinides
  5.3.1 Overview
  5.3.2 Meglitinides Market Size and Forecast
5.4 Alpha-glucosidase Inhibitors
  5.4.1 Overview
  5.4.2 Alpha-glucosidase Inhibitors Market Size and Forecast
5.5 Others
  5.5.1 Overview
  5.5.2 Others Market Size and Forecast
5.6 Others
  5.6.1 Overview
  5.6.2 Others Market Size and Forecast

6 CONCLUSION

LIST OF TABLES

Tab Regional Production 2011-2017 (Million USD)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Million USD)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Million USD)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Million USD)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Eli Lilly
Tab Sales Revenue, Volume, Price, Cost and Margin of Merck
Tab Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Tab Sales Revenue, Volume, Price, Cost and Margin of Abbott
Tab Sales Revenue, Volume, Price, Cost and Margin of Biocon
Tab Sales Revenue, Volume, Price, Cost and Margin of Sanofi
Tab Sales Revenue, Volume, Price, Cost and Margin of Sanofi
Tab Sales Revenue, Volume, Price, Cost and Margin of Novartis
Tab Sales Revenue, Volume, Price, Cost and Margin of Novo Nordisk
Tab Sales Revenue, Volume, Price, Cost and Margin of Boehringer Ingelheim
Tab Sales Revenue, Volume, Price, Cost and Margin of Takeda Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of Oramed Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of Jiangsu Wanbang
Tab Sales Revenue, Volume, Price, Cost and Margin of Nanjing Xinbai

LIST OF FIGURES

Fig Global Oral Antidiabetic Drugs Market Size and CAGR 2011-2017 (Million USD)
Fig Global Oral Antidiabetic Drugs Market Size and CAGR 2011-2017 (Volume)
Fig Global Oral Antidiabetic Drugs Market Forecast and CAGR 2018-2025 (Million USD)
Fig Global Oral Antidiabetic Drugs Market Forecast and CAGR 2018-2025 (Volume)
Fig Hospitals Market Size and CAGR 2011-2017 (Million USD)
Fig Hospitals Market Size and CAGR 2011-2017 (Volume)
Fig Hospitals Market Forecast and CAGR 2018-2025 (Million USD)
Fig Hospitals Market Forecast and CAGR 2018-2025 (Volume)
Fig Clinics Market Size and CAGR 2011-2017 (Million USD)
Fig Clinics Market Size and CAGR 2011-2017 (Volume)
Fig Clinics Market Forecast and CAGR 2018-2025 (Million USD)
Fig Clinics Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Million USD)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Million USD)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)
Fig Sulfonylureas Market Size and CAGR 2011-2017 (Million USD)
Fig Sulfonylureas Market Size and CAGR 2011-2017 (Volume)
Fig Sulfonylureas Market Forecast and CAGR 2018-2025 (Million USD)
Fig Sulfonylureas Market Forecast and CAGR 2018-2025 (Volume)
Fig Biguanides Market Size and CAGR 2011-2017 (Million USD)
Fig Biguanides Market Size and CAGR 2011-2017 (Volume)
Fig Biguanides Market Forecast and CAGR 2018-2025 (Million USD)
Fig Biguanides Market Forecast and CAGR 2018-2025 (Volume)
Fig Meglitinides Market Size and CAGR 2011-2017 (Million USD)
Fig Meglitinides Market Size and CAGR 2011-2017 (Volume)
Fig Meglitinides Market Forecast and CAGR 2018-2025 (Million USD)
Fig Meglitinides Market Forecast and CAGR 2018-2025 (Volume)
Fig Alpha-glucosidase Inhibitors Market Size and CAGR 2011-2017 (Million USD)
Fig Alpha-glucosidase Inhibitors Market Size and CAGR 2011-2017 (Volume)
Fig Alpha-glucosidase Inhibitors Market Forecast and CAGR 2018-2025 (Million USD)
Fig Alpha-glucosidase Inhibitors Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Million USD)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Million USD)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Million USD)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Million USD)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)


More Publications